Case Presentations: Pre-Invasive Cervical Neoplasia

Slides:



Advertisements
Similar presentations
MANAGEMENT OF ABNORMAL PAP SMEAR
Advertisements

In the name of God Isfahan medical school Shahnaz Aram MD.
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Cervical Cancer American Cancer Society Georgia Department of Human Resources The University of Georgia Cooperative Extension Service.
IL BCCP Questions.
Updates on Pap Smear Guidelines 2014
Treatment Options for CIN Cervical Cancer screening is designed to detect CIN If CIN is present treatment should theoretically avoid subsequent cancer.
Cervix Dr. Raid Jastania. Cervical Cancer Screening HPV infection Pre- Cancerous Dysplasia Cancer years.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Benign Conditions Of The Cervix Dr. Abdalla H. Elsadig MD.
Screening for Cervical Cancer
Management of Women with CIN 1 or LSIL
Benign and premalignant disease of the cervix
Cervical Cancer Source: SEER’s Training Web Site
Cervical Cancer: Prevention and Treatment
Jacqueline Castagno, MD FACOG Division of Gynecologic Oncology Department of Obstetrics and Gynecology University of Florida College of Medicine.
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
PRE-INVASIVE DISEASE OF THE CERVIX CERVICAL INTRAEPHELIAL NEOPLASIA DR. AMEL AL-SAYED Asst. Prof. & Consultant Ob/Gyne Dept.
COLPOSCOPY Cervical Screening QARC Training School October 2012.
HPV: How to prevent your patients from becoming my patients Katina Robison, MD Assistant Professor, Department of Obstetrics & Gynecology Director of Colposcopy.
Cervical Cancer Screening
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Screening for Cervical Cancer Max Brinsmead MB BS PhD May 2015.
Abnormal Pap in Pregnancy Alexander Burnett, MD Division Gyn Oncology, UAMS April, 2006.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Current guidelines for Cervical Cancer Screening
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
Cervical Intraepithelial Neoplasm
KATIE OSTROM PAPS, ABORTION, AND VACUUM DELIVERY.
The up-to-date evidence on colposcopy practice
Adult Medical-Surgical Nursing
TEMPLATE DESIGN © Outcome of Large Loop Excision of Transformation Zone (LLETZ ) in women over forty at two London Hospitals.
Premalignant lesions of the cervix. Applied anatomy.
1www.zohrehyousefi.com. 2 Major risk factors: smoking immunosuppression organ transplantation HIV infectionCigarette smoking, nutritional deficiency,
CERVICAL SCREENING ANGELIKA KAUFMANN, ST4, UHCW, MEDICAL STUDENT INDUCTION, 2015.
What is a Pap smear? is a medical procedure in which a sample of cells from a woman's cervix is collected and spread (smeared) on a microscope slide.
COLPOSCOPY QUESTIONS Michael R. Downs M.D. October 2004.
2006 ASCCP Consensus Guidelines Anne L. Kittendorf, MD FAAFP Assistant Professor University of Michigan Department of Family Medicine.
HPV and Pap Guidelines Jennifer Johnson MD. Objectives 1. Define the new PAP guidelines. 2. Identify the historical trends and new evidence resulting.
Treatment for Cervical Cancer
To pap or not to pap: and what to do when you do Kimberly Swan MD Minimally Invasive Gynecologic Surgery Assistant Professor Ob/Gyn University of Kansas.
HPV AND WOMEN’S CANCER A.C. Evans. M.D., Ph.D.. HPV and Women’s Cancer I have no relevant financial relationships with the manufacturer(s) of any commercial.
HPV-related anogenital cancers
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
Dr. Ahmed jasim Ass.Prof.MBChB-DOG-FICMS COSULTANT OF GYN. & OBST. COSULTANT OF GYN. & OBST.
Cytopathology Feb
Understanding Test Results
Trreatment of Preinvasive Lesions
Cytology Codes & management Colposcopy- Management of cervical lesions
Cervical Cancer Colposcopy & Treatment
Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.
Dr N Shailaja Dr Pradeep
Colposcopy triage. Satisfactory colposcopy is defined as complete visualization of the squamocolumnar epithelium, which comprises the cervical region most.
F.Behnamfar Gynecology Oncology Fellow Professor
Updates on Pap Smear Guidelines 2014
Management of the Abnormal Pap Smear.
SBÜ KAYSERİ ERH Doç. Dr. Gökhan Açmaz
AGC&AIS Setareh Akhavan M.D Gynecologist Oncologist
Cervical Screening for Dysplasia and Cancer in Patients with HIV
ای نام تو بهترین سرآغاز، بی نام تو نامه کی کنم باز ای هست کن هرآنچه هستند نام تو کلید هرچه بستند
Cervical excisional treatment of young women: A population-based study
SH-sheikhhasani Gyn-oncologist
Presentation transcript:

Case Presentations: Pre-Invasive Cervical Neoplasia Kathleen M. Schmeler, M.D. Assistant Professor Department of Gynecologic Oncology

Case #1 25 yo Smokes 1 pack of cigarettes per day Routine Pap test: high-grade squamous intraepithelial lesion (HSIL) Next step? 2

Case #1 Cervical biopsy: CIN 3 Endocervical curettage: CIN 3 4

CIN 2/3 5% of women undergoing Pap tests in the USA Typically diagnosed between age 25 and 35 years Progresses to cancer 8 to 13 years after a diagnosis of CIN 2/3 Caused by persistent infection with high-risk HPV subtypes HPV infection is necessary but not sufficient to develop CIN 2/3 6

CIN 2/3 Co-Factors HIV infection Immunosuppressive therapy (renal transplant, chemotherapy) Cigarette smoking 7

Case #1 Treatment for CIN 2/3? 8

Cervical Conization Cold knife conization (CKC) Loop electrosurgical procedure (LEEP), also known as large loop excision of the transformation zone (LLETZ) Laser conization ** Hysterectomy should not be performed as the initial treatment for CIN 2/3 10

Complications of LEEP/CKC Intraoperative or postoperative bleeding Infection Cervical stenosis Infertility Pregnancy loss/Preterm birth: - CKC = 14% preterm birth rate - LEEP = 11% preterm delivery rate 11

Prognosis Untreated CIN 3: Risk of cancer is 20% at 10 years and 31% at 30 years Treated CIN 3: Risk of cancer is 0.3% at 10 years and 0.7% at 30 years McCredie et al., Lancet Onc, 2008 12

Hysterectomy Hysterectomy should NOT be performed as initial treatment for CIN 2/3 Hysterectomy indicated if: - Positive margins for CIN 2/3 and repeat excision not technically possible - Cervix/vagina scarring limiting follow-up exam - Persistent/recurrent CIN 2/3 * Consider frozen cone before hysterectomy if positive margins 13

Case #1 What if patient were pregnant with CIN3? 14

Pregnancy Do NOT treat CIN 2/3 during pregnancy Perform excision only if cancer suspected Up to 70% regress in postpartum period Significant bleeding and risk of preterm labor if treated during pregnancy ECC should never be performed during pregnancy Repeat cytology and colposcopy 6 to 12 weeks postpartum 15

Case #2 45 yo Routine Pap test shows atypical glandular cells? Work-up? 16

Case #2 Colposcopy: negative Endocervical curettage: adenocarcinoma-in-situ Endometrial biopsy: negative Next steps? 17

Case #2 Cone biopsy: adenocarcinoma-in-situ with positive margins Next steps? 18

Case #2 Repeat cone biopsy: no residual disease Next step? 19

Case #2 Hysterectomy: no residual disease 20

Adenocarcinoma-in-Situ (AIS) Atypical glandular cells without invasion Precursor to adenocarcinoma of the cervix (25% of cervical cancers) HPV infection is required (similar to squamous lesions) 10 - 13% of patients have multi-focal disease (“skip lesions”) 50% of patients have concomitant squamous dysplasia or cancer 21

Adenocarcinoma-in-Situ (AIS) Recommend CKC over LEEP due to higher probability of negative margins and no thermal artifact Standard treatment for AIS is hysterectomy once child-bearing is complete If positive cone margins, recommend repeat cone prior to hysterectomy to reduce the possibility of missing an occult cancer and performing incorrect procedure 22

Thank You 23